

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | L-phenylalanine catabolic process (GO:0006559) | 7.69322635 |
| 2 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.69322635 |
| 3 | L-phenylalanine metabolic process (GO:0006558) | 7.43630108 |
| 4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 7.43630108 |
| 5 | aromatic amino acid family catabolic process (GO:0009074) | 6.99085269 |
| 6 | tryptophan catabolic process (GO:0006569) | 6.34264284 |
| 7 | indole-containing compound catabolic process (GO:0042436) | 6.34264284 |
| 8 | indolalkylamine catabolic process (GO:0046218) | 6.34264284 |
| 9 | epoxygenase P450 pathway (GO:0019373) | 6.32413638 |
| 10 | glyoxylate metabolic process (GO:0046487) | 6.16276124 |
| 11 | kynurenine metabolic process (GO:0070189) | 6.06555398 |
| 12 | tryptophan metabolic process (GO:0006568) | 5.96748795 |
| 13 | cysteine metabolic process (GO:0006534) | 5.88330561 |
| 14 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.77045400 |
| 15 | bile acid biosynthetic process (GO:0006699) | 5.77007977 |
| 16 | serine family amino acid catabolic process (GO:0009071) | 5.51892549 |
| 17 | sulfur amino acid catabolic process (GO:0000098) | 5.51706992 |
| 18 | homocysteine metabolic process (GO:0050667) | 5.36300807 |
| 19 | * urea metabolic process (GO:0019627) | 5.35736123 |
| 20 | * urea cycle (GO:0000050) | 5.35736123 |
| 21 | lysine metabolic process (GO:0006553) | 5.28150632 |
| 22 | lysine catabolic process (GO:0006554) | 5.28150632 |
| 23 | negative regulation of fibrinolysis (GO:0051918) | 5.27147630 |
| 24 | alpha-linolenic acid metabolic process (GO:0036109) | 5.26750874 |
| 25 | omega-hydroxylase P450 pathway (GO:0097267) | 5.16150061 |
| 26 | aromatic amino acid family metabolic process (GO:0009072) | 5.11784944 |
| 27 | high-density lipoprotein particle remodeling (GO:0034375) | 5.09673930 |
| 28 | protein carboxylation (GO:0018214) | 5.05496927 |
| 29 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.05496927 |
| 30 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 5.05024818 |
| 31 | regulation of fibrinolysis (GO:0051917) | 4.99798250 |
| 32 | complement activation, alternative pathway (GO:0006957) | 4.95906014 |
| 33 | regulation of protein activation cascade (GO:2000257) | 4.94594266 |
| 34 | amino-acid betaine metabolic process (GO:0006577) | 4.92642783 |
| 35 | * nitrogen cycle metabolic process (GO:0071941) | 4.90370061 |
| 36 | alpha-amino acid catabolic process (GO:1901606) | 4.85316805 |
| 37 | bile acid metabolic process (GO:0008206) | 4.85208776 |
| 38 | tyrosine metabolic process (GO:0006570) | 4.82644335 |
| 39 | NADH metabolic process (GO:0006734) | 4.76063481 |
| 40 | serine family amino acid metabolic process (GO:0009069) | 4.64112434 |
| 41 | glycine metabolic process (GO:0006544) | 4.63936378 |
| 42 | regulation of complement activation (GO:0030449) | 4.62146753 |
| 43 | ethanol metabolic process (GO:0006067) | 4.52570649 |
| 44 | drug catabolic process (GO:0042737) | 4.50666377 |
| 45 | cellular amino acid catabolic process (GO:0009063) | 4.49627362 |
| 46 | regulation of triglyceride catabolic process (GO:0010896) | 4.49263198 |
| 47 | regulation of cholesterol esterification (GO:0010872) | 4.48202973 |
| 48 | indolalkylamine metabolic process (GO:0006586) | 4.46897214 |
| 49 | serine family amino acid biosynthetic process (GO:0009070) | 4.46611505 |
| 50 | reverse cholesterol transport (GO:0043691) | 4.42243622 |
| 51 | glutamate metabolic process (GO:0006536) | 4.42023139 |
| 52 | plasma lipoprotein particle remodeling (GO:0034369) | 4.40490239 |
| 53 | protein-lipid complex remodeling (GO:0034368) | 4.40490239 |
| 54 | macromolecular complex remodeling (GO:0034367) | 4.40490239 |
| 55 | negative regulation of cholesterol transport (GO:0032375) | 4.39560410 |
| 56 | negative regulation of sterol transport (GO:0032372) | 4.39560410 |
| 57 | cellular modified amino acid catabolic process (GO:0042219) | 4.39414510 |
| 58 | amine catabolic process (GO:0009310) | 4.34769470 |
| 59 | cellular biogenic amine catabolic process (GO:0042402) | 4.34769470 |
| 60 | cellular ketone body metabolic process (GO:0046950) | 4.33674626 |
| 61 | aldehyde catabolic process (GO:0046185) | 4.33120643 |
| 62 | urate metabolic process (GO:0046415) | 4.29641121 |
| 63 | coenzyme catabolic process (GO:0009109) | 4.27329605 |
| 64 | triglyceride homeostasis (GO:0070328) | 4.26343703 |
| 65 | acylglycerol homeostasis (GO:0055090) | 4.26343703 |
| 66 | complement activation, classical pathway (GO:0006958) | 4.25630478 |
| 67 | imidazole-containing compound metabolic process (GO:0052803) | 4.25356332 |
| 68 | cellular glucuronidation (GO:0052695) | 4.20650512 |
| 69 | benzene-containing compound metabolic process (GO:0042537) | 4.19008500 |
| 70 | dicarboxylic acid biosynthetic process (GO:0043650) | 4.18924352 |
| 71 | plasma lipoprotein particle clearance (GO:0034381) | 4.16473285 |
| 72 | phospholipid efflux (GO:0033700) | 4.14071970 |
| 73 | drug transmembrane transport (GO:0006855) | 4.12419549 |
| 74 | exogenous drug catabolic process (GO:0042738) | 4.09667851 |
| 75 | bile acid and bile salt transport (GO:0015721) | 4.09639101 |
| 76 | ethanol oxidation (GO:0006069) | 4.04417181 |
| 77 | carboxylic acid catabolic process (GO:0046395) | 3.89235413 |
| 78 | organic acid catabolic process (GO:0016054) | 3.89235413 |
| 79 | acetyl-CoA metabolic process (GO:0006084) | 3.88614220 |
| 80 | short-chain fatty acid metabolic process (GO:0046459) | 3.85995649 |
| 81 | aspartate family amino acid catabolic process (GO:0009068) | 3.85105025 |
| 82 | complement activation (GO:0006956) | 3.83502716 |
| 83 | glucuronate metabolic process (GO:0019585) | 3.83285724 |
| 84 | uronic acid metabolic process (GO:0006063) | 3.83285724 |
| 85 | fibrinolysis (GO:0042730) | 3.82107895 |
| 86 | cholesterol efflux (GO:0033344) | 3.81096464 |
| 87 | cofactor catabolic process (GO:0051187) | 3.76968918 |
| 88 | oxaloacetate metabolic process (GO:0006107) | 3.75088363 |
| 89 | 2-oxoglutarate metabolic process (GO:0006103) | 3.74822898 |
| 90 | negative regulation of protein activation cascade (GO:2000258) | 3.73848822 |
| 91 | ketone body metabolic process (GO:1902224) | 3.73848434 |
| 92 | phenylpropanoid metabolic process (GO:0009698) | 3.71208488 |
| 93 | low-density lipoprotein particle remodeling (GO:0034374) | 3.70403798 |
| 94 | regulation of cholesterol homeostasis (GO:2000188) | 3.70392683 |
| 95 | * arginine metabolic process (GO:0006525) | 3.69772017 |
| 96 | proline metabolic process (GO:0006560) | 3.67395335 |
| 97 | NAD biosynthetic process (GO:0009435) | 3.66139591 |
| 98 | plasma lipoprotein particle assembly (GO:0034377) | 3.65733179 |
| 99 | primary alcohol catabolic process (GO:0034310) | 3.65172250 |
| 100 | pyridine nucleotide biosynthetic process (GO:0019363) | 3.64887167 |
| 101 | nicotinamide nucleotide biosynthetic process (GO:0019359) | 3.64887167 |
| 102 | protein activation cascade (GO:0072376) | 3.62617952 |
| 103 | phospholipid homeostasis (GO:0055091) | 3.62157074 |
| 104 | cholesterol homeostasis (GO:0042632) | 3.58621181 |
| 105 | regulation of bile acid biosynthetic process (GO:0070857) | 3.57822790 |
| 106 | carnitine metabolic process (GO:0009437) | 3.56607074 |
| 107 | intestinal absorption (GO:0050892) | 3.56596835 |
| 108 | sterol homeostasis (GO:0055092) | 3.54907566 |
| 109 | flavonoid metabolic process (GO:0009812) | 3.54638508 |
| 110 | desmosome organization (GO:0002934) | 3.54436787 |
| 111 | regulation of plasminogen activation (GO:0010755) | 3.53097801 |
| 112 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.51779787 |
| 113 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.51779787 |
| 114 | blood coagulation, intrinsic pathway (GO:0007597) | 3.51128830 |
| 115 | drug metabolic process (GO:0017144) | 3.51076158 |
| 116 | drug transport (GO:0015893) | 3.50383432 |
| 117 | hormone catabolic process (GO:0042447) | 3.47808407 |
| 118 | negative regulation of complement activation (GO:0045916) | 3.47400636 |
| 119 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.39094401 |
| 120 | * midgut development (GO:0007494) | 3.37414910 |
| 121 | negative regulation of lipase activity (GO:0060192) | 3.36984739 |
| 122 | citrulline biosynthetic process (GO:0019240) | 3.28707350 |
| 123 | proline biosynthetic process (GO:0006561) | 3.28188239 |
| 124 | polyketide metabolic process (GO:0030638) | 3.26002784 |
| 125 | doxorubicin metabolic process (GO:0044598) | 3.26002784 |
| 126 | daunorubicin metabolic process (GO:0044597) | 3.26002784 |
| 127 | Golgi transport vesicle coating (GO:0048200) | 3.24867826 |
| 128 | COPI coating of Golgi vesicle (GO:0048205) | 3.24867826 |
| 129 | L-serine metabolic process (GO:0006563) | 3.20967274 |
| 130 | positive regulation of lipid catabolic process (GO:0050996) | 3.19324739 |
| 131 | oxidative demethylation (GO:0070989) | 3.15605040 |
| 132 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 3.11358358 |
| 133 | fat-soluble vitamin biosynthetic process (GO:0042362) | 3.10701372 |
| 134 | negative regulation of hemostasis (GO:1900047) | 3.09356450 |
| 135 | negative regulation of blood coagulation (GO:0030195) | 3.09356450 |
| 136 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 3.02560904 |
| 137 | triglyceride catabolic process (GO:0019433) | 3.01335799 |
| 138 | aminoglycoside antibiotic metabolic process (GO:0030647) | 3.00378398 |
| 139 | response to mercury ion (GO:0046689) | 3.00290337 |
| 140 | fructose metabolic process (GO:0006000) | 3.00067149 |
| 141 | primary alcohol metabolic process (GO:0034308) | 2.99861439 |
| 142 | folic acid metabolic process (GO:0046655) | 2.97917700 |
| 143 | regulation of cholesterol metabolic process (GO:0090181) | 2.95619612 |
| 144 | * glutamine family amino acid biosynthetic process (GO:0009084) | 2.93195341 |
| 145 | biotin metabolic process (GO:0006768) | 2.91716881 |
| 146 | negative regulation of fatty acid biosynthetic process (GO:0045717) | 2.91030810 |
| 147 | negative regulation of coagulation (GO:0050819) | 2.89971228 |
| 148 | acylglycerol catabolic process (GO:0046464) | 2.88415434 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 8.25122959 |
| 2 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 7.12004268 |
| 3 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 6.69435340 |
| 4 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 6.28134891 |
| 5 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 5.11171909 |
| 6 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 5.03546351 |
| 7 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.90615863 |
| 8 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 4.47481868 |
| 9 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 4.05318393 |
| 10 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.82316668 |
| 11 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.70815908 |
| 12 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.21932354 |
| 13 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.17379614 |
| 14 | * TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 2.08997794 |
| 15 | * ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 11.7122617 |
| 16 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.75370653 |
| 17 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.74703828 |
| 18 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.69951669 |
| 19 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.63717566 |
| 20 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.62440071 |
| 21 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.60029068 |
| 22 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.59123310 |
| 23 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.57872382 |
| 24 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.57295461 |
| 25 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.55547622 |
| 26 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.49928615 |
| 27 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.46828982 |
| 28 | * KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.45045438 |
| 29 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.44831982 |
| 30 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.43032028 |
| 31 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.42994538 |
| 32 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.39855520 |
| 33 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.38054271 |
| 34 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.36425993 |
| 35 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.36314144 |
| 36 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.32582755 |
| 37 | ATF3_27146783_Chip-Seq_COLON_Human | 1.30760353 |
| 38 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.26880575 |
| 39 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.26756562 |
| 40 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.26750491 |
| 41 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.25984955 |
| 42 | GATA1_22025678_ChIP-Seq_K562_Human | 1.25319397 |
| 43 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.25210865 |
| 44 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.25161386 |
| 45 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.22698500 |
| 46 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.22617890 |
| 47 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.21456968 |
| 48 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.21076408 |
| 49 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.19968489 |
| 50 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.19085573 |
| 51 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.18739407 |
| 52 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.18197051 |
| 53 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.17765932 |
| 54 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.16693299 |
| 55 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.15468762 |
| 56 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.14601167 |
| 57 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.12216780 |
| 58 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.11859780 |
| 59 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.10282197 |
| 60 | * HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.09732197 |
| 61 | * KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.09535308 |
| 62 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.09172523 |
| 63 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.05040902 |
| 64 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 1.03929446 |
| 65 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.01494674 |
| 66 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.01419145 |
| 67 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.00941106 |
| 68 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.00742217 |
| 69 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.98157608 |
| 70 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.97186949 |
| 71 | P68_20966046_ChIP-Seq_HELA_Human | 0.96638074 |
| 72 | * NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.95903066 |
| 73 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.95025275 |
| 74 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.94557591 |
| 75 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 0.94286741 |
| 76 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.93196459 |
| 77 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 0.93026452 |
| 78 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.91213501 |
| 79 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.91213501 |
| 80 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.91074929 |
| 81 | * TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.90511074 |
| 82 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.90270525 |
| 83 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.89555179 |
| 84 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.87986124 |
| 85 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 0.87556045 |
| 86 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.87469187 |
| 87 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 0.86734656 |
| 88 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.86386354 |
| 89 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 0.86211087 |
| 90 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.83904215 |
| 91 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.81150014 |
| 92 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.79536877 |
| 93 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.79274580 |
| 94 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.78893677 |
| 95 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.78025772 |
| 96 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.74444212 |
| 97 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.74046329 |
| 98 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.71684087 |
| 99 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.69536757 |
| 100 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 0.69466977 |
| 101 | * LXR_22292898_ChIP-Seq_THP-1_Human | 0.68994667 |
| 102 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.68433754 |
| 103 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.66885452 |
| 104 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.66479670 |
| 105 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.63148425 |
| 106 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.62240177 |
| 107 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.60860244 |
| 108 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.59887917 |
| 109 | * RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.59718628 |
| 110 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.59100657 |
| 111 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.59049000 |
| 112 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.54654553 |
| 113 | AR_20517297_ChIP-Seq_VCAP_Human | 0.52404704 |
| 114 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.51712642 |
| 115 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.51357882 |
| 116 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.51357882 |
| 117 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.50850107 |
| 118 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.50765814 |
| 119 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.47392562 |
| 120 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.47037381 |
| 121 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.46892585 |
| 122 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.46862228 |
| 123 | SOX2_18692474_ChIP-Seq_MEFs_Mouse | 0.46315315 |
| 124 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.46311819 |
| 125 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.46139563 |
| 126 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.46033304 |
| 127 | AR_21909140_ChIP-Seq_LNCAP_Human | 0.45917709 |
| 128 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.45830735 |
| 129 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.45320528 |
| 130 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.45058012 |
| 131 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.44568281 |
| 132 | * ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.43945497 |
| 133 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.43629987 |
| 134 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.43201461 |
| 135 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.43025349 |
| 136 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.42637059 |
| 137 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.42414147 |
| 138 | * OCT4_18692474_ChIP-Seq_MEFs_Mouse | 0.41703873 |
| 139 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.41483449 |
| 140 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.41411887 |
| 141 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.41073973 |
| 142 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 0.40926059 |
| 143 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.40878235 |
| 144 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.40283552 |
| 145 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.40243819 |
| 146 | NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 0.39230290 |
| 147 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.39013842 |
| 148 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.38725583 |
| 149 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 0.38618567 |
| 150 | * TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.38432163 |
| 151 | CBP_21632823_ChIP-Seq_H3396_Human | 0.38264155 |
| 152 | NANOG_16518401_ChIP-PET_MESCs_Mouse | 0.38238394 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 7.91560732 |
| 2 | MP0005360_urolithiasis | 7.80643364 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 6.08689283 |
| 4 | MP0005365_abnormal_bile_salt | 5.85248134 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 4.94324338 |
| 6 | MP0003806_abnormal_nucleotide_metabolis | 4.38016372 |
| 7 | MP0003252_abnormal_bile_duct | 3.81141200 |
| 8 | MP0010234_abnormal_vibrissa_follicle | 3.31106265 |
| 9 | MP0010329_abnormal_lipoprotein_level | 3.29513382 |
| 10 | MP0009840_abnormal_foam_cell | 3.21546472 |
| 11 | * MP0005332_abnormal_amino_acid | 3.12437395 |
| 12 | MP0003195_calcinosis | 3.11355632 |
| 13 | MP0005083_abnormal_biliary_tract | 2.81101752 |
| 14 | MP0004019_abnormal_vitamin_homeostasis | 2.60921458 |
| 15 | MP0001666_abnormal_nutrient_absorption | 2.40351252 |
| 16 | MP0002138_abnormal_hepatobiliary_system | 2.33987221 |
| 17 | MP0008438_abnormal_cutaneous_collagen | 2.32194013 |
| 18 | MP0003191_abnormal_cellular_cholesterol | 2.27246569 |
| 19 | MP0000609_abnormal_liver_physiology | 2.10369775 |
| 20 | MP0002118_abnormal_lipid_homeostasis | 1.97854679 |
| 21 | MP0005319_abnormal_enzyme/_coenzyme | 1.91967196 |
| 22 | MP0001764_abnormal_homeostasis | 1.74859937 |
| 23 | MP0010352_gastrointestinal_tract_polyps | 1.68395884 |
| 24 | MP0003868_abnormal_feces_composition | 1.67251786 |
| 25 | MP0009643_abnormal_urine_homeostasis | 1.65653882 |
| 26 | MP0004858_abnormal_nervous_system | 1.60613311 |
| 27 | MP0004272_abnormal_basement_membrane | 1.57870326 |
| 28 | * MP0005584_abnormal_enzyme/coenzyme_acti | 1.57104981 |
| 29 | MP0004185_abnormal_adipocyte_glucose | 1.48737218 |
| 30 | MP0005501_abnormal_skin_physiology | 1.48150868 |
| 31 | MP0005451_abnormal_body_composition | 1.47932485 |
| 32 | * MP0003186_abnormal_redox_activity | 1.43632450 |
| 33 | MP0000579_abnormal_nail_morphology | 1.42879866 |
| 34 | MP0003941_abnormal_skin_development | 1.38418285 |
| 35 | MP0003705_abnormal_hypodermis_morpholog | 1.33740021 |
| 36 | MP0009697_abnormal_copulation | 1.28218117 |
| 37 | MP0009379_abnormal_foot_pigmentation | 1.26452183 |
| 38 | MP0010030_abnormal_orbit_morphology | 1.25348990 |
| 39 | MP0005375_adipose_tissue_phenotype | 1.25223381 |
| 40 | MP0005409_darkened_coat_color | 1.24793589 |
| 41 | MP0000598_abnormal_liver_morphology | 1.23229930 |
| 42 | MP0002060_abnormal_skin_morphology | 1.23144222 |
| 43 | MP0003011_delayed_dark_adaptation | 1.22066962 |
| 44 | MP0003566_abnormal_cell_adhesion | 1.21969376 |
| 45 | MP0000003_abnormal_adipose_tissue | 1.21949000 |
| 46 | MP0002098_abnormal_vibrissa_morphology | 1.19926924 |
| 47 | MP0005636_abnormal_mineral_homeostasis | 1.19569898 |
| 48 | MP0005076_abnormal_cell_differentiation | 1.18565646 |
| 49 | MP0009764_decreased_sensitivity_to | 1.17629585 |
| 50 | MP0000467_abnormal_esophagus_morphology | 1.12948167 |
| 51 | MP0000537_abnormal_urethra_morphology | 1.12494782 |
| 52 | MP0003656_abnormal_erythrocyte_physiolo | 1.12041687 |
| 53 | MP0001849_ear_inflammation | 1.11688261 |
| 54 | MP0005275_abnormal_skin_tensile | 1.08228068 |
| 55 | MP0000604_amyloidosis | 1.03108748 |
| 56 | MP0009763_increased_sensitivity_to | 1.02077115 |
| 57 | MP0000566_synostosis | 1.01895186 |
| 58 | MP0008469_abnormal_protein_level | 1.00421252 |
| 59 | MP0003879_abnormal_hair_cell | 0.97727339 |
| 60 | MP0002249_abnormal_larynx_morphology | 0.96930716 |
| 61 | MP0005647_abnormal_sex_gland | 0.96125562 |
| 62 | MP0001756_abnormal_urination | 0.95237475 |
| 63 | MP0004233_abnormal_muscle_weight | 0.94852610 |
| 64 | MP0005257_abnormal_intraocular_pressure | 0.94802251 |
| 65 | MP0000462_abnormal_digestive_system | 0.92293335 |
| 66 | MP0005670_abnormal_white_adipose | 0.91832265 |
| 67 | MP0002254_reproductive_system_inflammat | 0.91292886 |
| 68 | MP0006036_abnormal_mitochondrial_physio | 0.90765874 |
| 69 | MP0000477_abnormal_intestine_morphology | 0.90734654 |
| 70 | MP0000490_abnormal_crypts_of | 0.89224092 |
| 71 | * MP0009642_abnormal_blood_homeostasis | 0.88721555 |
| 72 | MP0005408_hypopigmentation | 0.88384480 |
| 73 | MP0000678_abnormal_parathyroid_gland | 0.88190636 |
| 74 | MP0000762_abnormal_tongue_morphology | 0.83867112 |
| 75 | MP0002136_abnormal_kidney_physiology | 0.83488237 |
| 76 | MP0005376_homeostasis/metabolism_phenot | 0.82744572 |
| 77 | MP0005084_abnormal_gallbladder_morpholo | 0.82733360 |
| 78 | MP0005503_abnormal_tendon_morphology | 0.80710186 |
| 79 | MP0009780_abnormal_chondrocyte_physiolo | 0.80639519 |
| 80 | MP0002896_abnormal_bone_mineralization | 0.79096846 |
| 81 | MP0000013_abnormal_adipose_tissue | 0.78959278 |
| 82 | MP0009765_abnormal_xenobiotic_induced | 0.77688617 |
| 83 | MP0006138_congestive_heart_failure | 0.77490156 |
| 84 | MP0003183_abnormal_peptide_metabolism | 0.77079245 |
| 85 | MP0004043_abnormal_pH_regulation | 0.75600557 |
| 86 | MP0002876_abnormal_thyroid_physiology | 0.75127888 |
| 87 | MP0002078_abnormal_glucose_homeostasis | 0.71663181 |
| 88 | MP0002877_abnormal_melanocyte_morpholog | 0.70597567 |
| 89 | MP0005266_abnormal_metabolism | 0.69157437 |
| 90 | MP0005220_abnormal_exocrine_pancreas | 0.69042784 |
| 91 | MP0001664_abnormal_digestion | 0.67766187 |
| 92 | MP0001661_extended_life_span | 0.67611631 |
| 93 | MP0005535_abnormal_body_temperature | 0.67550277 |
| 94 | MP0000538_abnormal_urinary_bladder | 0.66757226 |
| 95 | * MP0001216_abnormal_epidermal_layer | 0.66731873 |
| 96 | MP0003959_abnormal_lean_body | 0.66693612 |
| 97 | MP0010368_abnormal_lymphatic_system | 0.66610627 |
| 98 | MP0003693_abnormal_embryo_hatching | 0.65648717 |
| 99 | MP0005058_abnormal_lysosome_morphology | 0.65369746 |
| 100 | MP0003436_decreased_susceptibility_to | 0.65019196 |
| 101 | MP0005623_abnormal_meninges_morphology | 0.64799948 |
| 102 | MP0010771_integument_phenotype | 0.63874793 |
| 103 | MP0004957_abnormal_blastocyst_morpholog | 0.63618728 |
| 104 | MP0009053_abnormal_anal_canal | 0.63468557 |
| 105 | MP0000627_abnormal_mammary_gland | 0.62220225 |
| 106 | MP0002971_abnormal_brown_adipose | 0.62184440 |
| 107 | MP0005334_abnormal_fat_pad | 0.59933961 |
| 108 | MP0005197_abnormal_uvea_morphology | 0.59792983 |
| 109 | MP0005395_other_phenotype | 0.59773657 |
| 110 | MP0006035_abnormal_mitochondrial_morpho | 0.59632315 |
| 111 | MP0003329_amyloid_beta_deposits | 0.59459755 |
| 112 | MP0005464_abnormal_platelet_physiology | 0.56440800 |
| 113 | MP0004130_abnormal_muscle_cell | 0.55128790 |
| 114 | MP0003690_abnormal_glial_cell | 0.54462653 |
| 115 | MP0003724_increased_susceptibility_to | 0.53976091 |
| 116 | MP0003718_maternal_effect | 0.53012759 |
| 117 | MP0001765_abnormal_ion_homeostasis | 0.51967052 |
| 118 | MP0003638_abnormal_response/metabolism_ | 0.51702825 |
| 119 | MP0002928_abnormal_bile_duct | 0.50714072 |
| 120 | MP0008873_increased_physiological_sensi | 0.49149337 |
| 121 | MP0002168_other_aberrant_phenotype | 0.48553985 |
| 122 | MP0006082_CNS_inflammation | 0.48275186 |
| 123 | MP0003075_altered_response_to | 0.47978780 |
| 124 | MP0001853_heart_inflammation | 0.47619529 |
| 125 | MP0001845_abnormal_inflammatory_respons | 0.43980831 |
| 126 | MP0005166_decreased_susceptibility_to | 0.43697067 |
| 127 | MP0000639_abnormal_adrenal_gland | 0.43576778 |
| 128 | MP0005448_abnormal_energy_balance | 0.42892129 |
| 129 | MP0005666_abnormal_adipose_tissue | 0.42015403 |
| 130 | MP0004782_abnormal_surfactant_physiolog | 0.41915464 |
| 131 | MP0008874_decreased_physiological_sensi | 0.40961888 |
| 132 | MP0002796_impaired_skin_barrier | 0.39102386 |
| 133 | MP0002135_abnormal_kidney_morphology | 0.37648342 |
| 134 | MP0003953_abnormal_hormone_level | 0.36697514 |
| 135 | MP0009672_abnormal_birth_weight | 0.36305455 |
| 136 | MP0008872_abnormal_physiological_respon | 0.35754487 |
| 137 | MP0000230_abnormal_systemic_arterial | 0.34446447 |
| 138 | MP0001243_abnormal_dermal_layer | 0.33157393 |
| 139 | MP0009115_abnormal_fat_cell | 0.32716210 |
| 140 | MP0000249_abnormal_blood_vessel | 0.32557607 |
| 141 | MP0005023_abnormal_wound_healing | 0.31422949 |
| 142 | MP0002970_abnormal_white_adipose | 0.30749295 |
| 143 | MP0004264_abnormal_extraembryonic_tissu | 0.29965724 |
| 144 | MP0009785_altered_susceptibility_to | 0.29532722 |
| 145 | MP0004883_abnormal_blood_vessel | 0.29123012 |
| 146 | MP0001881_abnormal_mammary_gland | 0.28959521 |
| 147 | MP0003453_abnormal_keratinocyte_physiol | 0.26789184 |
| 148 | MP0005164_abnormal_response_to | 0.26636341 |
| 149 | MP0004947_skin_inflammation | 0.26375982 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 7.33853809 |
| 2 | Intrahepatic cholestasis (HP:0001406) | 6.84832542 |
| 3 | Deep venous thrombosis (HP:0002625) | 6.69939840 |
| 4 | * Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.29909635 |
| 5 | Xanthomatosis (HP:0000991) | 6.10207581 |
| 6 | Hypobetalipoproteinemia (HP:0003563) | 5.85912685 |
| 7 | Prolonged partial thromboplastin time (HP:0003645) | 5.83494707 |
| 8 | Hyperlipoproteinemia (HP:0010980) | 5.10340829 |
| 9 | Complement deficiency (HP:0004431) | 4.75615476 |
| 10 | * Hyperammonemia (HP:0001987) | 4.57539935 |
| 11 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 4.52273947 |
| 12 | Hyperglycinemia (HP:0002154) | 4.51228614 |
| 13 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 4.49325582 |
| 14 | Hyperglycinuria (HP:0003108) | 4.48819956 |
| 15 | Joint hemorrhage (HP:0005261) | 4.48187723 |
| 16 | * Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.40531044 |
| 17 | Hypolipoproteinemia (HP:0010981) | 4.39984101 |
| 18 | Ketosis (HP:0001946) | 4.36517944 |
| 19 | Abnormality of methionine metabolism (HP:0010901) | 4.30897015 |
| 20 | Abnormality of serine family amino acid metabolism (HP:0010894) | 4.28502360 |
| 21 | Abnormality of glycine metabolism (HP:0010895) | 4.28502360 |
| 22 | Epidermoid cyst (HP:0200040) | 4.19563597 |
| 23 | Abnormality of the common coagulation pathway (HP:0010990) | 4.05647567 |
| 24 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.00998741 |
| 25 | Hypoalphalipoproteinemia (HP:0003233) | 3.85840133 |
| 26 | Fat malabsorption (HP:0002630) | 3.85174845 |
| 27 | Hypoglycemic coma (HP:0001325) | 3.73866571 |
| 28 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.55396928 |
| 29 | Abnormality of complement system (HP:0005339) | 3.52167023 |
| 30 | Gout (HP:0001997) | 3.43469556 |
| 31 | * Abnormality of pyrimidine metabolism (HP:0004353) | 3.41711701 |
| 32 | Abnormality of the intrinsic pathway (HP:0010989) | 3.36382805 |
| 33 | Conjugated hyperbilirubinemia (HP:0002908) | 3.32515468 |
| 34 | Hypercholesterolemia (HP:0003124) | 3.30528300 |
| 35 | * Abnormality of nucleobase metabolism (HP:0010932) | 3.29069508 |
| 36 | Delayed CNS myelination (HP:0002188) | 3.25628856 |
| 37 | Abnormality of purine metabolism (HP:0004352) | 3.23323057 |
| 38 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.21898416 |
| 39 | Protrusio acetabuli (HP:0003179) | 3.21489419 |
| 40 | Ketoacidosis (HP:0001993) | 3.20953549 |
| 41 | Hyperbilirubinemia (HP:0002904) | 3.16606302 |
| 42 | Premature rupture of membranes (HP:0001788) | 3.14352742 |
| 43 | Hepatocellular carcinoma (HP:0001402) | 3.00099966 |
| 44 | Metabolic acidosis (HP:0001942) | 2.90178563 |
| 45 | Steatorrhea (HP:0002570) | 2.89486125 |
| 46 | * Abnormality of serum amino acid levels (HP:0003112) | 2.89347548 |
| 47 | Myocardial infarction (HP:0001658) | 2.86348562 |
| 48 | Vascular calcification (HP:0004934) | 2.85746042 |
| 49 | Spastic diplegia (HP:0001264) | 2.77171720 |
| 50 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.76803314 |
| 51 | Dicarboxylic aciduria (HP:0003215) | 2.76803314 |
| 52 | Systemic lupus erythematosus (HP:0002725) | 2.71879698 |
| 53 | * Lethargy (HP:0001254) | 2.70606993 |
| 54 | Spontaneous abortion (HP:0005268) | 2.68000288 |
| 55 | Nephritis (HP:0000123) | 2.67462190 |
| 56 | Generalized aminoaciduria (HP:0002909) | 2.63515322 |
| 57 | Proximal tubulopathy (HP:0000114) | 2.61812083 |
| 58 | Skin nodule (HP:0200036) | 2.61191601 |
| 59 | Vertebral compression fractures (HP:0002953) | 2.59294150 |
| 60 | Abnormality of the Achilles tendon (HP:0005109) | 2.58982199 |
| 61 | Cardiovascular calcification (HP:0011915) | 2.55175793 |
| 62 | Hypochromic microcytic anemia (HP:0004840) | 2.49929214 |
| 63 | Asymmetry of the thorax (HP:0001555) | 2.49234955 |
| 64 | Back pain (HP:0003418) | 2.45798872 |
| 65 | Malnutrition (HP:0004395) | 2.44662476 |
| 66 | * Irritability (HP:0000737) | 2.40727707 |
| 67 | Right ventricular cardiomyopathy (HP:0011663) | 2.40021743 |
| 68 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.38035818 |
| 69 | Hyperuricemia (HP:0002149) | 2.36974273 |
| 70 | Increased purine levels (HP:0004368) | 2.36974273 |
| 71 | Abnormality of proline metabolism (HP:0010907) | 2.36048212 |
| 72 | Hydroxyprolinuria (HP:0003080) | 2.36048212 |
| 73 | Mitral stenosis (HP:0001718) | 2.33748596 |
| 74 | Abnormality of glycolysis (HP:0004366) | 2.28794559 |
| 75 | Glomerulonephritis (HP:0000099) | 2.26098582 |
| 76 | Esophageal varix (HP:0002040) | 2.24961112 |
| 77 | Abdominal distention (HP:0003270) | 2.24043556 |
| 78 | Hypoglycemic seizures (HP:0002173) | 2.22684085 |
| 79 | Pancreatitis (HP:0001733) | 2.22614623 |
| 80 | Rickets (HP:0002748) | 2.21546741 |
| 81 | * Vomiting (HP:0002013) | 2.20936686 |
| 82 | Sensorimotor neuropathy (HP:0007141) | 2.20297213 |
| 83 | Abnormal gallbladder morphology (HP:0012437) | 2.17403922 |
| 84 | Enlarged kidneys (HP:0000105) | 2.16374500 |
| 85 | Acanthocytosis (HP:0001927) | 2.16261654 |
| 86 | Abnormal enzyme/coenzyme activity (HP:0012379) | 2.15977843 |
| 87 | Pterygium (HP:0001059) | 2.15750331 |
| 88 | * Cerebral edema (HP:0002181) | 2.14940130 |
| 89 | Abnormal hair laboratory examination (HP:0003328) | 2.14560626 |
| 90 | Thin bony cortex (HP:0002753) | 2.14272874 |
| 91 | Cholelithiasis (HP:0001081) | 2.13872106 |
| 92 | Late onset (HP:0003584) | 2.13562600 |
| 93 | * Alkalosis (HP:0001948) | 2.13176232 |
| 94 | Increased serum pyruvate (HP:0003542) | 2.12242267 |
| 95 | Glycosuria (HP:0003076) | 2.11177787 |
| 96 | Abnormality of urine glucose concentration (HP:0011016) | 2.11177787 |
| 97 | Pili torti (HP:0003777) | 2.10797470 |
| 98 | * Neonatal onset (HP:0003623) | 2.10647202 |
| 99 | Abnormality of carpal bone ossification (HP:0006257) | 2.08967026 |
| 100 | Cholecystitis (HP:0001082) | 2.08926892 |
| 101 | Abnormal gallbladder physiology (HP:0012438) | 2.08926892 |
| 102 | Amyloidosis (HP:0011034) | 2.08650802 |
| 103 | Achilles tendon contracture (HP:0001771) | 2.08590145 |
| 104 | Thrombophlebitis (HP:0004418) | 2.08584921 |
| 105 | Opisthotonus (HP:0002179) | 2.05990498 |
| 106 | Abnormal cartilage morphology (HP:0002763) | 2.04486458 |
| 107 | Gingival bleeding (HP:0000225) | 2.03115011 |
| 108 | Reduced antithrombin III activity (HP:0001976) | 2.00419780 |
| 109 | Flat acetabular roof (HP:0003180) | 1.99022071 |
| 110 | Nausea (HP:0002018) | 1.98327640 |
| 111 | Menorrhagia (HP:0000132) | 1.98023772 |
| 112 | Abnormal delivery (HP:0001787) | 1.96361590 |
| 113 | Hyperactive renin-angiotensin system (HP:0000841) | 1.96241335 |
| 114 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.94521076 |
| 115 | Brushfield spots (HP:0001088) | 1.93927440 |
| 116 | Abnormality of iron homeostasis (HP:0011031) | 1.92283010 |
| 117 | Hemorrhage of the eye (HP:0011885) | 1.91884871 |
| 118 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.91836052 |
| 119 | Fragile skin (HP:0001030) | 1.90762532 |
| 120 | Focal segmental glomerulosclerosis (HP:0000097) | 1.89618402 |
| 121 | Hypophosphatemic rickets (HP:0004912) | 1.86836684 |
| 122 | Elevated alkaline phosphatase (HP:0003155) | 1.86458771 |
| 123 | Ulnar bowing (HP:0003031) | 1.86224738 |
| 124 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.84749011 |
| 125 | Abnormal tarsal ossification (HP:0008369) | 1.83461080 |
| 126 | Abnormality of the gallbladder (HP:0005264) | 1.81934026 |
| 127 | Atrophic scars (HP:0001075) | 1.81282434 |
| 128 | Blue sclerae (HP:0000592) | 1.80436910 |
| 129 | Renal tubular acidosis (HP:0001947) | 1.79749442 |
| 130 | Popliteal pterygium (HP:0009756) | 1.78666094 |
| 131 | Abnormality of vitamin metabolism (HP:0100508) | 1.75811528 |
| 132 | Hypophosphatemia (HP:0002148) | 1.75649324 |
| 133 | Glomerulosclerosis (HP:0000096) | 1.74816902 |
| 134 | Acanthosis nigricans (HP:0000956) | 1.73543173 |
| 135 | Nephrolithiasis (HP:0000787) | 1.73187380 |
| 136 | Ileus (HP:0002595) | 1.71944580 |
| 137 | Wide cranial sutures (HP:0010537) | 1.71766933 |
| 138 | Abnormality of the gastric mucosa (HP:0004295) | 1.71619584 |
| 139 | Abnormality of the distal phalanges of the toes (HP:0010182) | 1.70806300 |
| 140 | Ankle contracture (HP:0006466) | 1.69216674 |
| 141 | Biconcave vertebral bodies (HP:0004586) | 1.68933282 |
| 142 | Hyperparathyroidism (HP:0000843) | 1.68925734 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 7.19392815 |
| 2 | FGFR4 | 4.50840524 |
| 3 | ERN1 | 4.34218186 |
| 4 | SIK1 | 3.84793249 |
| 5 | ERBB4 | 2.75567320 |
| 6 | SMG1 | 2.51612528 |
| 7 | EEF2K | 2.50566192 |
| 8 | TAOK3 | 2.33686510 |
| 9 | ICK | 2.16690623 |
| 10 | PKN2 | 2.15346981 |
| 11 | MST1R | 2.11298245 |
| 12 | INSRR | 2.06038555 |
| 13 | FLT3 | 1.94792226 |
| 14 | TYK2 | 1.91896661 |
| 15 | MAPK11 | 1.83789789 |
| 16 | TRIB3 | 1.83573081 |
| 17 | ABL2 | 1.79252981 |
| 18 | MAP2K4 | 1.70411071 |
| 19 | WNK4 | 1.64528958 |
| 20 | RPS6KB2 | 1.63718642 |
| 21 | PAK4 | 1.61729682 |
| 22 | PRPF4B | 1.61134380 |
| 23 | MUSK | 1.60051218 |
| 24 | WNK3 | 1.57936969 |
| 25 | TBK1 | 1.49747172 |
| 26 | STK38L | 1.49297792 |
| 27 | MAP2K2 | 1.48953217 |
| 28 | PIK3CG | 1.48234079 |
| 29 | NEK9 | 1.47420951 |
| 30 | SCYL2 | 1.46874305 |
| 31 | PDGFRA | 1.42780462 |
| 32 | LATS1 | 1.35147810 |
| 33 | PTK6 | 1.34733000 |
| 34 | MAP3K14 | 1.31479238 |
| 35 | TESK1 | 1.31284932 |
| 36 | GRK6 | 1.30555400 |
| 37 | KDR | 1.30467238 |
| 38 | NEK1 | 1.30413516 |
| 39 | LMTK2 | 1.27773048 |
| 40 | MAPKAPK3 | 1.24904614 |
| 41 | MAP2K3 | 1.21537967 |
| 42 | EPHB2 | 1.15077086 |
| 43 | MAP3K11 | 1.14100209 |
| 44 | JAK2 | 1.14031193 |
| 45 | MYLK | 1.11741124 |
| 46 | TTK | 1.11539746 |
| 47 | MAP3K3 | 1.09336892 |
| 48 | PRKG2 | 1.07907930 |
| 49 | NTRK1 | 1.05108710 |
| 50 | PINK1 | 1.03611535 |
| 51 | IRAK3 | 1.03411280 |
| 52 | PIK3CA | 1.01988633 |
| 53 | OXSR1 | 1.00841269 |
| 54 | EPHA2 | 1.00784563 |
| 55 | JAK1 | 1.00380124 |
| 56 | CDK12 | 0.99999750 |
| 57 | MAP3K2 | 0.96333127 |
| 58 | PBK | 0.95149294 |
| 59 | NEK6 | 0.94833615 |
| 60 | PIM2 | 0.93976195 |
| 61 | EPHB1 | 0.92740617 |
| 62 | MET | 0.92471947 |
| 63 | DAPK2 | 0.91019134 |
| 64 | MAP3K7 | 0.90806473 |
| 65 | MAP3K10 | 0.89514923 |
| 66 | NME1 | 0.87118439 |
| 67 | ERBB2 | 0.86561982 |
| 68 | FRK | 0.86150013 |
| 69 | MAP3K12 | 0.85347575 |
| 70 | DDR2 | 0.84264906 |
| 71 | PRKAA2 | 0.83896730 |
| 72 | CDK6 | 0.83498619 |
| 73 | MAPK4 | 0.80080183 |
| 74 | CDK7 | 0.79394914 |
| 75 | ARAF | 0.79329951 |
| 76 | PDK4 | 0.77766309 |
| 77 | PDK3 | 0.77766309 |
| 78 | CSK | 0.77540930 |
| 79 | DYRK1B | 0.77433653 |
| 80 | PRKCZ | 0.76358209 |
| 81 | ILK | 0.75565716 |
| 82 | GSK3A | 0.75366800 |
| 83 | PTK2 | 0.72223026 |
| 84 | IKBKE | 0.69807929 |
| 85 | TAOK2 | 0.68625182 |
| 86 | STK39 | 0.67719632 |
| 87 | KSR2 | 0.66015753 |
| 88 | PRKACG | 0.65039769 |
| 89 | SGK3 | 0.62775714 |
| 90 | FGFR2 | 0.61960440 |
| 91 | MAP3K5 | 0.61683937 |
| 92 | NME2 | 0.61180604 |
| 93 | FER | 0.60498426 |
| 94 | ACVR1B | 0.59813858 |
| 95 | EPHA3 | 0.58661571 |
| 96 | MAP3K1 | 0.57809366 |
| 97 | CDK4 | 0.56562855 |
| 98 | CSF1R | 0.56392590 |
| 99 | MAPK12 | 0.54440871 |
| 100 | MAP3K8 | 0.54208035 |
| 101 | AKT2 | 0.53748797 |
| 102 | BLK | 0.53337084 |
| 103 | MAP2K6 | 0.53103796 |
| 104 | PRKAA1 | 0.52940467 |
| 105 | AURKB | 0.52848093 |
| 106 | TGFBR2 | 0.52719965 |
| 107 | MAP4K1 | 0.51052134 |
| 108 | BRAF | 0.50620435 |
| 109 | RIPK1 | 0.49854307 |
| 110 | MAP3K6 | 0.49265825 |
| 111 | BMX | 0.48334509 |
| 112 | CAMK2G | 0.47998455 |
| 113 | BRSK1 | 0.46304541 |
| 114 | PDPK1 | 0.46260984 |
| 115 | FGFR3 | 0.45400353 |
| 116 | MAP3K13 | 0.44553064 |
| 117 | LRRK2 | 0.44370124 |
| 118 | PAK2 | 0.42620124 |
| 119 | ZAP70 | 0.41673051 |
| 120 | PDK2 | 0.41469021 |
| 121 | IKBKB | 0.40450589 |
| 122 | MTOR | 0.40319598 |
| 123 | STK16 | 0.39669940 |
| 124 | PRKCI | 0.39589547 |
| 125 | SGK494 | 0.38305756 |
| 126 | SGK223 | 0.38305756 |
| 127 | EIF2AK1 | 0.37599302 |
| 128 | EGFR | 0.37545421 |
| 129 | MAP2K1 | 0.36747244 |
| 130 | RET | 0.36716416 |
| 131 | TIE1 | 0.36253224 |
| 132 | SGK2 | 0.36133711 |
| 133 | IGF1R | 0.35825802 |
| 134 | JAK3 | 0.35338577 |
| 135 | MELK | 0.34366966 |
| 136 | PRKCQ | 0.33697891 |
| 137 | AURKA | 0.33178395 |
| 138 | CHUK | 0.33101509 |
| 139 | RPS6KA2 | 0.33040588 |
| 140 | TTN | 0.31531104 |
| 141 | MAPK7 | 0.31511999 |
| 142 | TESK2 | 0.31498317 |
| 143 | KIT | 0.30836853 |
| 144 | PIM1 | 0.30598689 |
| 145 | CAMK2D | 0.30245526 |
| 146 | MAPK15 | 0.29979133 |
| 147 | CSNK1G1 | 0.27818935 |
| 148 | MAPKAPK5 | 0.27259690 |
| 149 | LATS2 | 0.27054064 |
| 150 | STK38 | 0.26825196 |
| 151 | CDK8 | 0.26692741 |
| 152 | CDC42BPA | 0.26353026 |
| 153 | DAPK3 | 0.26261580 |
| 154 | PDK1 | 0.25779919 |
| 155 | MAP3K9 | 0.25251022 |
| 156 | SRPK1 | 0.25035287 |
| 157 | CAMK2B | 0.24646683 |
| 158 | STK24 | 0.21984019 |
| 159 | RPS6KB1 | 0.20963109 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.26313757 |
| 2 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.64148383 |
| 3 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.60872415 |
| 4 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.45396841 |
| 5 | * Arginine biosynthesis_Homo sapiens_hsa00220 | 2.94907636 |
| 6 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.75769057 |
| 7 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.69731375 |
| 8 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.67816219 |
| 9 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.51343707 |
| 10 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.47932580 |
| 11 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.46824814 |
| 12 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.46228390 |
| 13 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.43176792 |
| 14 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.21809830 |
| 15 | Peroxisome_Homo sapiens_hsa04146 | 2.14629074 |
| 16 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.00970972 |
| 17 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.00357843 |
| 18 | Histidine metabolism_Homo sapiens_hsa00340 | 1.87139611 |
| 19 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.82348255 |
| 20 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.82065498 |
| 21 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.80260444 |
| 22 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.77779224 |
| 23 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.77309522 |
| 24 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.76832158 |
| 25 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.75398488 |
| 26 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.73874098 |
| 27 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.65767559 |
| 28 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.65610228 |
| 29 | * Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.65549075 |
| 30 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.63307165 |
| 31 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.62422688 |
| 32 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.62360903 |
| 33 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.60922368 |
| 34 | Retinol metabolism_Homo sapiens_hsa00830 | 1.54846549 |
| 35 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.47517690 |
| 36 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.46332529 |
| 37 | Bile secretion_Homo sapiens_hsa04976 | 1.44164770 |
| 38 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.40077939 |
| 39 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.35495618 |
| 40 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.34568161 |
| 41 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.30837631 |
| 42 | * Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.30605542 |
| 43 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.30432562 |
| 44 | Carbon metabolism_Homo sapiens_hsa01200 | 1.29338271 |
| 45 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.26378505 |
| 46 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.13423063 |
| 47 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.11155722 |
| 48 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.09377753 |
| 49 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.09188082 |
| 50 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.05406671 |
| 51 | ABC transporters_Homo sapiens_hsa02010 | 1.03208325 |
| 52 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.98604037 |
| 53 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.98001833 |
| 54 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.94298891 |
| 55 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.93675263 |
| 56 | Sulfur relay system_Homo sapiens_hsa04122 | 0.93604773 |
| 57 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.87704106 |
| 58 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.83741489 |
| 59 | Lysine degradation_Homo sapiens_hsa00310 | 0.83233812 |
| 60 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.82109306 |
| 61 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.81396989 |
| 62 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.78602495 |
| 63 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.74122457 |
| 64 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.72613146 |
| 65 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.66819150 |
| 66 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.58293134 |
| 67 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.47873461 |
| 68 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.41116030 |
| 69 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.36859667 |
| 70 | Thyroid cancer_Homo sapiens_hsa05216 | 0.35193501 |
| 71 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.31603832 |
| 72 | Galactose metabolism_Homo sapiens_hsa00052 | 0.30706351 |
| 73 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.30375826 |
| 74 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.29855315 |
| 75 | Prion diseases_Homo sapiens_hsa05020 | 0.27082607 |
| 76 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.26312476 |
| 77 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.21114531 |
| 78 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.19332213 |
| 79 | Insulin resistance_Homo sapiens_hsa04931 | 0.19079750 |
| 80 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.17322384 |
| 81 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.16662466 |
| 82 | Amoebiasis_Homo sapiens_hsa05146 | 0.15658612 |
| 83 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.14453629 |
| 84 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.09452650 |
| 85 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.09063036 |
| 86 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.08112116 |
| 87 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.06964132 |
| 88 | Tight junction_Homo sapiens_hsa04530 | 0.05297179 |
| 89 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.03913370 |
| 90 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.02896313 |
| 91 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.01348892 |
| 92 | Ribosome_Homo sapiens_hsa03010 | 0.01228471 |
| 93 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | -0.2028330 |
| 94 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.2013534 |
| 95 | Bladder cancer_Homo sapiens_hsa05219 | -0.1982126 |
| 96 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | -0.1867045 |
| 97 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | -0.1863865 |
| 98 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.1853801 |
| 99 | Legionellosis_Homo sapiens_hsa05134 | -0.1833129 |
| 100 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | -0.1794807 |
| 101 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.1759627 |
| 102 | Mineral absorption_Homo sapiens_hsa04978 | -0.1732217 |
| 103 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.1653862 |
| 104 | Other glycan degradation_Homo sapiens_hsa00511 | -0.1601084 |
| 105 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.1530347 |
| 106 | Hepatitis C_Homo sapiens_hsa05160 | -0.1450801 |
| 107 | Lysosome_Homo sapiens_hsa04142 | -0.1292950 |
| 108 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.1268651 |
| 109 | Regulation of autophagy_Homo sapiens_hsa04140 | -0.0988529 |
| 110 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.0644411 |
| 111 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.0598595 |
| 112 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | -0.0594012 |
| 113 | AMPK signaling pathway_Homo sapiens_hsa04152 | -0.0157729 |
| 114 | Sphingolipid metabolism_Homo sapiens_hsa00600 | -0.0068074 |

